These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9056112)

  • 1. Decreased Tamm-Horsfall protein in lithiasic patients.
    Romero MC; Nocera S; Nesse AB
    Clin Biochem; 1997 Feb; 30(1):63-7. PubMed ID: 9056112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new ELISA method for the rapid quantification of Tamm-Horsfall protein in urine.
    Reinhart HH; Obedeanu N; Walz D; Sobel JD
    Am J Clin Pathol; 1989 Aug; 92(2):199-205. PubMed ID: 2756935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease.
    Lau WH; Leong WS; Ismail Z; Gam LH
    Int J Biol Sci; 2008 Aug; 4(4):215-22. PubMed ID: 18695745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients.
    Ganter K; Bongartz D; Hesse A
    Urology; 1999 Mar; 53(3):492-5. PubMed ID: 10096372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological detection of nitrosative stress-mediated modified Tamm-Horsfall glycoprotein (THP) in calcium oxalate stone formers.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Anandkumar P; Varalakshmi P
    Biomarkers; 2006; 11(2):153-63. PubMed ID: 16766391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of urinary Tamm-Horsfall protein by ELISA using a maleimide method for enzyme-antibody conjugation.
    Uto I; Ishimatsu T; Hirayama H; Ueda S; Tsuruta J; Kambara T
    J Immunol Methods; 1991 Apr; 138(1):87-94. PubMed ID: 2019749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein.
    Bleyer AJ; Hart TC; Shihabi Z; Robins V; Hoyer JR
    Kidney Int; 2004 Sep; 66(3):974-7. PubMed ID: 15327389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of urinary Tamm-Horsfall protein assay by enzyme-linked immunosorbent assay and establishment of reference range of healthy subject].
    Nishimaki J; Masuda M; Katoh S; Nakajima T; Kanamori K; Shimomura H; Shiba K
    Rinsho Byori; 2008 Oct; 56(10):862-7. PubMed ID: 19068782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients.
    Sumitra K; Pragasam V; Sakthivel R; Kalaiselvi P; Varalakshmi P
    Nephrol Dial Transplant; 2005 Jul; 20(7):1407-15. PubMed ID: 15855216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of urinary inhibitors of crystallization in uric acid nephrolithiasis: Dalmatian dog model.
    Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
    Urology; 2003 Sep; 62(3):566-70. PubMed ID: 12946778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditions for solubilization of Tamm-Horsfall protein/uromodulin in human urine and establishment of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) method.
    Kobayashi K; Fukuoka S
    Arch Biochem Biophys; 2001 Apr; 388(1):113-20. PubMed ID: 11361126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy.
    Knörle R; Schnierle P; Koch A; Buchholz NP; Hering F; Seiler H; Ackermann T; Rutishauser G
    Clin Chem; 1994 Sep; 40(9):1739-43. PubMed ID: 8070085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.
    Schnierle P
    Experientia; 1995 Nov; 51(11):1068-72. PubMed ID: 7498447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.